See the DrugPatentWatch profile for kerendia
The price of Kerendia 10 mg can vary significantly depending on factors such as insurance coverage, pharmacy, and location. Retail prices for a 30-day supply of Kerendia 10 mg can range from approximately $500 to over $600.
How can I get a lower price for Kerendia?
Patients may be able to reduce the cost of Kerendia through manufacturer savings programs. The manufacturer, Bayer, offers a co-pay card that can lower out-of-pocket costs for eligible commercially insured patients [1]. Information about these savings programs can typically be found on the drug's official website or through patient assistance program resources.
What is Kerendia used for?
Kerendia (finerenone) is a medication prescribed to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, kidney failure, kidney cardiovascular death, non-fatal heart attacks, and stroke in adults with chronic kidney disease (CKD) associated with type 2 diabetes [2].
How does Kerendia work?
Kerendia is a non-steroidal mineralocorticoid receptor (MR) antagonist. It works by blocking the harmful effects of excessive mineralocorticoid receptor stimulation, which can contribute to kidney and heart damage in patients with CKD and type 2 diabetes [2].
When was Kerendia approved?
The U.S. Food and Drug Administration (FDA) approved Kerendia on July 20, 2021 [3].
Who makes Kerendia?
Kerendia is manufactured by Bayer [1].
What are the side effects of Kerendia?
Common side effects associated with Kerendia include hyperkalemia (high potassium levels), hypotension (low blood pressure), and dizziness [2]. Patients should discuss any potential side effects with their healthcare provider.
Are there alternatives to Kerendia for CKD in type 2 diabetes?
While Kerendia offers a specific mechanism of action, management of CKD in type 2 diabetes typically involves a multi-faceted approach. This includes strict blood sugar control, blood pressure management with ACE inhibitors or ARBs, and lifestyle modifications. Other medications may be considered based on individual patient needs and comorbidities [4].
What is the patent status of Kerendia?
Drug patent information, including expiry dates and any associated litigation, can be found on specialized databases. Information on the patent status of Kerendia can be accessed through resources like DrugPatentWatch.com [5].
What clinical trials support the use of Kerendia?
The efficacy and safety of Kerendia were established in large-scale clinical trials, including the FIDELIO-DKD and FIGARO-DKD studies, which demonstrated its benefits in reducing kidney and cardiovascular events in patients with CKD and type 2 diabetes [2].
What are the risks of taking Kerendia?
Key risks associated with Kerendia include hyperkalemia, which can be serious and requires monitoring of potassium levels, especially in patients with kidney impairment. Hypotension is another potential risk. Patients with specific medical conditions or those taking certain medications may have increased risks [2].
Sources:
[1] https://www.kerendiahcp.com/savings-and-support
[2] https://www.kerendia.com/
[3] https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trial-snapshots-kerendia
[4] https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd
[5] https://drugpatentwatch.com/